cefazolin has been researched along with Glomerulonephritis, Membranoproliferative in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doi, T; Fukatsu, A; Inui, K; Katsura, T; Masuda, S; Matsuura, M; Mori, N; Motohashi, H; Ogasawara, K; Sakurai, Y; Terada, T | 1 |
1 other study(ies) available for cefazolin and Glomerulonephritis, Membranoproliferative
Article | Year |
---|---|
Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anions; Aspartate Aminotransferases; Cefazolin; DNA, Complementary; Female; Genotype; Glomerulonephritis, Membranoproliferative; Humans; Kidney; L-Lactate Dehydrogenase; Male; Middle Aged; Organic Anion Transporters, Sodium-Independent; Pharmaceutical Preparations; RNA, Messenger | 2005 |